$CNBX

CNBX PHARMACEUTICAL INC

Pharmaceutical preparations · OTCID

0.000 +100.00% as of 10/30/2026, 11:33:46 PM · delayed

Sentiment

BULLISH BEARISH

No open positions yet.

No threads yet for $CNBX. Be the first to post.

Official links

Filings

8-K Thu Oct 01 2026 00:00:00 GMT-0400 (Eastern Daylight Time) SEC.gov View
SCHEDULE 13G/A Fri Aug 14 2026 00:00:00 GMT-0400 (Eastern Daylight Time) SEC.gov
10-Q Wed Jun 24 2026 00:00:00 GMT-0400 (Eastern Daylight Time) SEC.gov View
SCHEDULE 13G/A Fri May 08 2026 00:00:00 GMT-0400 (Eastern Daylight Time) SEC.gov
10-Q Tue Apr 14 2026 00:00:00 GMT-0400 (Eastern Daylight Time) SEC.gov View
8-K Tue Mar 17 2026 00:00:00 GMT-0400 (Eastern Daylight Time) SEC.gov View
SCHEDULE 13G/A Thu Feb 05 2026 00:00:00 GMT-0500 (Eastern Standard Time) SEC.gov
10-Q Wed Jan 14 2026 00:00:00 GMT-0500 (Eastern Standard Time) SEC.gov View

All filings

Timeline

filing 9/30/2026 8-K filed
revenue 9/8/2026 Revenue reported: $0, year ended Aug 31, 2025
revenue 9/8/2026 Revenue reported: $130.1K, year ended Aug 31, 2024
revenue 9/8/2026 Revenue reported: $410.2K, year ended Aug 31, 2023
revenue 9/8/2026 Revenue reported: $30.0K, year ended Aug 31, 2022
revenue 9/8/2026 Revenue reported: $0, year ended Aug 31, 2021
revenue 9/8/2026 Revenue reported: $7.2K, year ended Aug 31, 2020
revenue 9/8/2026 Revenue reported: $9.8K, year ended Aug 31, 2019
revenue 9/8/2026 Revenue reported: $9.6K, year ended Aug 31, 2018
revenue 9/8/2026 Revenue reported: $5.7K, year ended Aug 31, 2017

Company reliability

–

No resolved statements yet.

Revenue

Quarterly

May 2026 $0
Feb 2026 $0
Nov 2025 $0
Aug 2025 $0 derived

Annual

FY 2025 $0
FY 2024 $130K
FY 2023 $410K

Source: SEC XBRL

CEO compensation

$222K (FY 2020)

All disclosed CEO pay: $638K since 2015 (may span more than one CEO)

10-K

Provisional - extracted from filings, not verified.

Latest disclosed; no newer filing found.

FY 2019 $258K extracted
FY 2017 $75K extracted

Notes & debt

Provisional - extracted from filings, not verified.

IN DEFAULT · $780K in arrears
$280K matured May 16, 2022 10-Q · 2026-06-24

Quote

Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant On March 16, 2022 the Company issued to the Investor a demand promissory note (the “Demand Note”) in the principal amount of $280,000 (the “Principal”) with an original issue discount of $40,000.
$65K matured Jun 12, 2023 5% 10-Q · 2026-06-24

Quote

On June 12, 2023, the Company entered into a Securities Purchase Agreement providing for the issuance of the Convertible Promissory Note in the principal amount of $ 65,000 .00. ($ 65,000 net of issuance expenses).
$35K matured Jun 12, 2023 9% 10-Q · 2026-06-24

Quote

The Convertible Promissory Note carry interest of 5 % and due on June 15 th 2023 On June 12, 2023, the Company entered into a Securities Purchase Agreement providing for the issuance of the Convertible Promissory Note in the principal amount of $ 65,000 .00. ($ 65,000 net of issuance expenses).
$25K matured Jan 1, 2025 5% 10-Q · 2026-06-24

Quote

On December 30, 2024, the Company entered into a Securities Purchase Agreement providing for the issuance of the Convertible Promissory Note in the principal amount of $ 25,000 ($ 25,000 net of issuance expenses).
$30K matured Jan 1, 2025 5% 10-Q · 2026-06-24

Quote

The Convertible Promissory Note carry interest of 5% and due on January 1, 2025.
$65K matured Jan 1, 2025 5% 10-Q · 2026-06-24

Quote

The Convertible Promissory Note carry interest of 5 % and due on August 5 th , 2023. 12 On September 24, 2024, the Company entered into a Securities Purchase Agreement providing for the issuance of the Convertible Promissory Note in the principal amount of $ 30,000 ($ 30,000 net of issuance expenses).
$55K matured Apr 1, 2025 5% 10-Q · 2026-06-24

Quote

On February 3, 2025, the Company entered into a Securities Purchase Agreement providing for the issuance of the Convertible Promissory Note in the principal amount of $ 55,000 ($ 50,000 net of issuance expenses).
$25K matured Apr 1, 2025 5% 10-Q · 2026-06-24

Quote

The Convertible Promissory Note carries an interest of 5% and is due on April 1, 2025 The Company has evaluated subsequent events through the date the financial statements were issued and filed with the SEC and has determined that there are no other such events that warrant disclosure or recognition in the financial statements. 12 Item 2.
$30K matured Jul 1, 2025 5% 10-Q · 2026-06-24

Quote

On June 23, 2025, the Company entered into a Securities Purchase Agreement providing for the issuance of the Convertible Promissory Note in the principal amount of $ 30,000 ($ 30,000 net of issuance expenses).
$20K matured Jul 1, 2025 5% 10-Q · 2026-06-24

Quote

The Convertible Promissory Note carry interest of 5% and due on July 1, 2025.
$20K matured Oct 30, 2025 10% 10-Q · 2026-06-24

Quote

On April 24, 2025, the Company entered into a Securities Purchase Agreement providing for the issuance of the Convertible Promissory Note in the principal amount of $ 20,000 ($ 20,000 net of issuance expenses).
$50K matured Oct 30, 2025 10% 10-Q · 2026-06-24

Quote

The Convertible Promissory Note carry interest of 10% and due on October 30, 2025.
$30K matured Dec 31, 2025 5% 10-Q · 2026-06-24

Quote

The Convertible Promissory Note carry interest of 5% and due on December 31, 2025.
$50K matured Oct 1, 2026 5% 10-Q · 2026-06-24

Quote

The Non-Convertible Promissory Note carry interest of 5% and due on October 1, 2026.
NEARING / AGED
$1.4M — 10-Q · 2026-06-24

Quote

On April 23, 2021, we entered into a senior secured promissory note (the “Senior Secured Note”) for $ 1,375,000 with the institutional investor.
OTHER ISSUANCES
$2.8M — 10-Q · 2026-06-24

Quote

Note 5 – Private Placement of Notes and Warrant On December 16, 2020, we entered into a Securities Purchase Agreement (“SPA”) with an institutional investor for a private placement of senior secured convertible notes totaling up to an aggregate of $2,750,000 to be issued in three tranches subject to the achievement of certain milestones.
$154K — 9% 10-Q · 2026-06-24

Quote

The Convertible Promissory Note carry interest of 9 % and due on June 15 th 2023 .
$154K — 9% 10-Q · 2026-06-24

Quote

On June 15, 2022, the Company entered into a Securities Purchase Agreement providing for the issuance of the Convertible Promissory Note in the principal amount of $ 154,250 .00. ($ 154,000 net of issuance expenses).
No notes match this filter.

Top predictors

No resolved predictions on $CNBX yet.

Upcoming resolutions

Nothing awaiting resolution.